title: Arylamidrazones as novel corticotropin releasing factor receptor antagonists.
abstract: The arylamidrazones have been found to be potent corticotropin releasing factor (CRF) receptor antagonists structurally distinct from previously reported CRF1 antagonists. Attempts to modify the arylamidrazone core suggested an important role for the anilino NH moiety. The right-hand-side 2-nitro feature in lead 1 could be replaced with substituents methyl, chloro, cyano, or trifluoromethyl with a 4- to 10-fold reduction in receptor binding. With appropriate left-hand-side modifications, this potency loss could be recovered.
authors.forename: Dean M
authors.initials: DM
authors.lastname: Wilson
authors.forename: Andreas P
authors.initials: AP
authors.lastname: Termin
authors.forename: Long
authors.initials: L
authors.lastname: Mao
authors.forename: Michele M
authors.initials: MM
authors.lastname: Ramirez-Weinhouse
authors.forename: Valentina
authors.initials: V
authors.lastname: Molteni
authors.forename: Peter D J
authors.initials: PD
authors.lastname: Grootenhuis
authors.forename: Keith
authors.initials: K
authors.lastname: Miller
authors.forename: Susan
authors.initials: S
authors.lastname: Keim
authors.forename: Gwendolyn
authors.initials: G
authors.lastname: Wise
mesh_terms: D000814:Aniline Compounds / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D006834:Hydrazines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D051381:Rats; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship; D000099052:CRF Receptor, Type 1
chemical_list: D000814:Aniline Compounds; D006834:Hydrazines; D018019:Receptors, Corticotropin-Releasing Hormone; D000099052:CRF Receptor, Type 1